Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.

@article{Svendsen2004DoesTC,
  title={Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.},
  author={Kristina Bacher Svendsen and Troels Staehelin Jensen and Flemming W Bach},
  journal={BMJ},
  year={2004},
  volume={329 7460},
  pages={253}
}
OBJECTIVE To evaluate the effect of the oral synthetic delta-9-tetrahydrocannabinol dronabinol on central neuropathic pain in patients with multiple sclerosis. DESIGN Randomised double blind placebo controlled crossover trial. SETTING Outpatient clinic, University Hospital of Aarhus, Denmark. PARTICIPANTS 24 patients aged between 23 and 55 years with multiple sclerosis and central pain. INTERVENTION Orally administered dronabinol at a maximum dose of 10 mg daily or corresponding placebo… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 156 extracted citations

Cannabinoids in the management of difficult to treat pain

Therapeutics and clinical risk management • 2008
View 8 Excerpts
Highly Influenced

Role of cannabinoids in multiple sclerosis.

View 12 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Similar Papers

Loading similar papers…